Cost-Effectiveness and Outcomes Research Setting value to what we do.

Slides:



Advertisements
Similar presentations
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlikeLicense. Your use of this material constitutes acceptance of that license.
Advertisements

ECONOMIC EVALUATION WHY DO YOU NEED TO BOTHER? JUDITH BOSMANS.
1 Are you sure your improvements are cost-effective? Edward Broughton, PhD, MPH, PT University Research Co. April 11, 2014
Cost-benefit and cost-effectiveness analysis: applications to health care programs and policies Greg Mason PRA Inc. and University of Manitoba October.
Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States Ian H. de Boer, MD, MS, Tessa C. Rue, MS, Yoshio N. Hall, MD, Patrick.
Economic Analysis and Management Todd Wagner, PhD.
Recommendations for Conducting Cost Effectiveness: Elements of the Reference Case Ciaran S. Phibbs, Ph.D. February 25, 2009.
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
Economic evaluation considers assessment of intervention effects in economic terms, which is often of greatest interest to fund allocators Intervention.
Journal Club Alcohol and Health: Current Evidence March-April 2006.
COST–EFFECTIVENESS ANALYSIS AND COST-UTILITY ANALYSIS
Schneider Institute for Health Policy Heller School Brandeis University September Donald S. Shepard, Ph.D. Schneider Institute for Health Policy.
Cost Effectiveness. Cost-Effectiveness and Outcomes Research Setting value to what we do.
AGEC 608 Lecture 17, p. 1 AGEC 608: Lecture 17 Objective: Review the main aspects of cost- effectiveness analysis (CEA) and cost-utility analysis (CUA).
University of Southern California Department of Pharmaceutical Economics and Policy 1540 E. Alcazar Street, CHP 140 Los Angeles, CA
The Benefits of Risk Factor Prevention in Americans Aged 51 Years and Older Dana P. Goldman, Federico Girosi et al. American Journal of Public Health November.
Clinical Management Nutr 564: Management Summer 2005.
Drug and Therapeutics Committee
Chapter 4: Economic Efficiency and Cost Benefit Analysis 1.Economic Efficiency 2.Cost Benefit Analysis.
Do we need economics in medicine?. Edmund Burke, 1790 dcist.com/2007/12/10/revisiting_edmu.php “…the age of chivalry is gone. That of sophisters, economists,
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 4 Economic Evaluation in Health Care.
Assessing cost-effectiveness – what is an ICER?- Incremental analysis
Public Policy Analysis MPA 404 Lecture 21. Previous Lecture Distribution of resources as a rationale for policy interventions The Social Welfare Function.
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
Cost Effectiveness Analysis To Enhance Mammography Use Dave Alvey Paul Moley.
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
1 Econoqualimetrics Edward Broughton, PhD., MPH Senior Economic Analyst, USAID Health Care Improvement Project, EnCompass,
© 2005, Johns Hopkins University. All rights reserved. Department of Health, Behavior & Society David Holtgrave, PhD, Professor & Chair.
BIOE 301 Lecture Thirteen. HIV/AIDS Vaccine Update.
Summary of measures of population Health Farid Najafi MD PhD School of Population Health Kermanshah University of Medical Sciences.
PHAR 310: Pharmacoeconomics
Evidence Evaluation & Methods Workgroup: Developing a Decision Analysis Model Lisa A. Prosser, PhD, MS September 23, 2011.
M Mohsen Ibrahim, MD CARDIOLOGY DEPARTMENT-CAIRO UNIVERSITY MINIMAL vs OPTIMAL MEDICAL CARE.
EVIDENCE BASED MEDICINE Health economics Ross Lawrenson.
Knowing what you get for what you pay An introduction to cost effectiveness FETP India.
Lecture Thirteen Biomedical Engineering for Global Health.
The Value of Medication Therapy Management Services.
Economic evaluation Definition - the comparative analysis of alternative courses of action in terms of both their cost and consequences.
Health Economics Unit Definition of Economics  Demand − relationship between quantities and prices that addresses how much bought at each price.
Phaedra Corso, Ph.D. Associate Professor College of Public Health University of Georgia Program Evaluation from an Economic Perspective.
Measuring Efficiency CRJS 4466EA. Introduction It is very important to understand the effectiveness of a program, as we have discovered in all earlier.
Basic Economic Analysis David Epstein, Centre for Health Economics, York.
Secondary Translation: Completing the process to Improving Health Daniel E. Ford, MD, MPH Vice Dean Johns Hopkins School of Medicine Introduction to Clinical.
Cost-Effectiveness and Cost-Benefit Analysis N287E Spring 2006 Joanne Spetz 31 May 2006.
انواع ارزيابي های اقتصادي سيدرضا مجدزاده مرکز تحقيقات بهره برداری از دانش سلامت و دانشکده بهداشت دانشگاه علوم پزشکي و خدمات بهداشتي درماني تهران.
NOR-MAN RHA Falls Prevention and Management Program February 2012.
Make Nutrition Services Count: Cost-Effectiveness Research & Outcomes Research.
PHARMACOECONOMICS Dr. Mohammad Aljawadi, PharmD PhD Department of Clinical Pharmacy King Saud University Aug, 2015 PHCL 431.
Cost-Effectiveness and Outcomes Research Setting value to what we do.
Promoting high quality, cost effective drug therapy throughout the Military Health System Identification and Use of Published Health Economic Evaluations.
Flagship Program on Health Sector Reform and Sustainable Financing.
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
BIOE 301 Lecture Sixteen. Review of Lectures What is the goal of cancer screening? Successful cancer screening examples? Can screening hurt more.
CRJS 4466 PROGRAM & POLICY EVALUATION LECTURE #6 Evaluation projects Questions?
Presentation Developed for the Academy of Managed Care Pharmacy
A Cost-Effectiveness Analysis of Maternal Genotyping to Guide Treatment in Postnatal Patients.
Chapter 14 Economic Analysis of Clinical and Managerial Interventions Copyright 2015 Health Administration Press.
How To Incorporate Measuring Costs into Research Design
HEALTH ECONOMICS BASICS
Global burden of diseases
Economic Evaluation of Health Interventions Basic Concepts
NAPLEX preparation: Biostatistics
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Sergio Bautista-Arredondo National Institute of Public Health Mexico
Biomedical Engineering for Global Health
BIOE 301 Lecture Sixteen.
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Presentation Developed for the Academy of Managed Care Pharmacy
Beneficence.
Presentation transcript:

Cost-Effectiveness and Outcomes Research Setting value to what we do

n n Define CE terms n n Review methods of evaluation in health care n n Review examples n n Identify activities that may promote CE studies Objectives:

n n What it is - “a method for evaluating the health outcomes and resource costs of health interventions” Russell, et al., JAMA 1996;276:1172 What is Cost-Effectiveness?

Interventions –Nutrition Support –MNT Protocols – Presence of the RD on the health care team, in the public health jurisdiction, etc.

What is Cost-Effectiveness? Outcomes in CEA –Traditional Medical Outcomes –Resource Costs –Expanded definition Patient centered outcomes Quality of life; Client satisfaction

What is Cost-Effectiveness? Cost-Savings Cheaper bang Cost-Benefit Analysis All benefits cost in dollars ?? Putting dollar value on life years What it is not - n n What it is -

n n Outcome The result of the performance (or nonperformance) of a function or process(es). n n Outcome Indicator Measures what happens (or does not happen) to a patient after something is done (or not done) to the patient. NLHI Terms

n n Cost Benefit Analysis An analytic tool for estimating the net social benefit of a program or intervention as the incremental benefit of the program less the incremental cost, with all benefits and costs measured in dollars. Terms

n n Cost Effectiveness An analytic tool in which costs and effects of a program and at least one alternative are calculated and presented in a ratio of incremental costs to incremental effects. Effects are health outcomes such as cases of a disease presented, years of life gained or quality adjusted life years rather than monetary measures as in cost benefit analysis. Terms

n n QALY “Quality-adjusted life year” “A measure of health outcome which assigns to each period of time a weight, ranging from 0 to 1, corresponding to the health-related quality of life during that period, where a weight of 1 corresponds to optimum health and a weight of 0 corresponds to a health state judged equivalent to death: these are then aggregated across time periods.” Gold 1996 Terms

n n DFLE “Disability-free life expectancy” Life expectancy free of class I (or worse) disability Disability classes based on person- trade off method

Objectives: n n Define CE terms n n Review methods of evaluation in health care n n Review examples n n Identify activities that may promote CE studies

n Outcomes Research –Process Identify the outcome (what we effect) Set a clear definition of the outcome –Implementation Measure Analyze Evaluate Features of Cost Effectiveness

Methods of Evaluation in Health Care: CEA Method of evaluation would be cost- effectiveness analysis (CEA). Only for mutually exclusive projects. t 1 CEA = costs in units of money benefits in mmHg and t 2 CEA = costs in units of money benefits in additional life years

Methods of Evaluation in Health Care Limitations of CEA n n Implies that it is not relevant who obtains the additional life years n n It does not lend itself to the evaluation of projects with several different (positive) effects. n n Provides a rank order of preference among mutually exclusive projects, it does not answer the question which of the projects should be realized and which should not

Methods of Evaluation in Health Care: Cost Utility Analysis Method of evaluation that takes account of the multidimensionality of the concept ‘health’ by trying to encompass all effects of an intervention - prolonging life and changing health status. t CUA = costs in units of money benefits in QALYs The index value may be interpreted as ‘QALYs’ gained. Again, only for mutually exclusive projects. Unlike CEA, suitable for comparing medical interventions of heterogeneous kind and purpose

Methods of Evaluation in Health Care: Cost Benefit Analysis Monetary equivalents are assigned to prolongations of life and change of health status. t CBA = costs in units of money benefits in units of money

Methods of Evaluation in Health Care: Unlike cost-benefit analysis, cost- effectiveness analysis and cost-utility analysis circumvent the problem of monetary evaluation of life and health. However, they provide only a relative evaluation of mutually exclusive projects, while CBA permits evaluation of each project on its own.

Objectives n n Define CE terms n n Review methods of evaluation in health care n n Review examples n n Identify activities that may promote CE studies

n n What is the question (intervention)? –Compared to what? n n Who is the decision maker? n n Over what time period for study? n n What is (are) the unit of outcome? Judith Barr, ScD; Director, National Education and Research Center for Outcomes Assessment in Healthcare Northeastern University, Boston MA Fundamental Health Economic Questions

Hoch JS: Health Econ. 11: 415–430 (2002), Published online 31 January 2002 in Wiley InterScience (

Intervention -- Weight Reduction Program Comparing usual care to dietitian consult Your Effects usual Your $ < usual A B Your $ > usual C D What can be said about A, B, C, and D? D -- Need for incremental cost-effectiveness Judith Barr, ScD; Director, National Education and Research Center for Outcomes Assessment in Healthcare Northeastern University, Boston MA Incremental Economic Analyses: 4 Possible Situations

Dietitian Usual Care Costs $2,500 $2,200 Effects 15 lbs 10 lbs n n What is the additional cost for an additional unit of gain? < ($2, ,200)/(15lbs-10lbs) = $300/5 or $60 for each additional pound lost. Judith Barr, ScD; Director, National Education and Research Center for Outcomes Assessment in Healthcare Northeastern University, Boston MA Incremental Cost-effectiveness

Dietitian Usual Care Costs $2,500 $2,200 Effects 20% 16% reduction in Hemoglobin A1c What is the additional cost for an additional unit of gain? Judith Barr, ScD; Director, National Education and Research Center for Outcomes Assessment in Healthcare Northeastern University, Boston MA Incremental Cost-effectiveness

Dietitian Usual Care Costs $2,500 $2,200 Effects 20% 16% n n ($ )/(20-16% reduction in HbA1c) n n $300/4% reduction in HbA1c n n $75/1% reduction in HbA1c Judith Barr, ScD; Director, National Education and Research Center for Outcomes Assessment in Healthcare Northeastern University, Boston MA Incremental Cost-effectiveness

League Tables progressive listing of costs per unit of effectiveness/outcome Unit of Outcome: Cost per Life Year Saved –Hypertension screening < 40 year male$9,800/LY < 40 year female$45,869/LY –Mammography 55-65yr women$44,550/LY –Pap screening (Pap Net) 20-65y$122,888/LY –Exercise ECG 40 yr male$135,116/LY –Exercise ECG 40 yr female$364,170/LY Judith Barr, ScD; Director, National Education and Research Center for Outcomes Assessment in Healthcare Northeastern University, Boston MA Cost-Effectiveness League Tables

Activities on CE Lewin Study n n A study at Group Health Cooperative in Puget Sound Area n n Covered dietitian services as a supplemental benefit for Medicare enrollees covered under risk contract n n Examined use and costs over time of services in this Medicare population with diabetes and CVD who did and did not use RD services Judith Barr, ScD; Director, National Education and Research Center for Outcomes Assessment in Healthcare Northeastern University, Boston MA

Activities on CE Lewin Study n n For DM patients using RD services hospital admissions were reduced by 9.5% and MD visits by 23.5% n n For CVD the use of RD services was associated with an 8.6% decrease in hospital utilization and a 16.9% decrease in MD visits. Judith Barr, ScD; Director, National Education and Research Center for Outcomes Assessment in Healthcare Northeastern University, Boston MA

Concept Checks n n What do you define as a limitation in demonstrating the cost-effectiveness of nutrition services –In clinical care –In prevention / PH

Concept Checks n n Comment on the findings of the Coffield study –Do you agree with the information in the figures? –What are the barriers to demonstrating the investment potential of nutrition and PA?